Showing results (391-400 of 442) with videos related to

Sort By:
Pageof 45
Toxicology Research|August 10, 2018
Systems toxicology meta-analysis of in vitro assessment studies: biological impact of a candidate modified-risk tobacco product aerosol compared with cigarette smoke on human organotypic cultures of the aerodigestive tractA R Iskandar, B Titz, A Sewer, et al.
Archives of General Psychiatry|July 1, 1986
Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatmentD Pickar, R Labarca, A R Doran, et al.
Nursing Research|June 8, 2001
Dyspnea and the affective response during exercise training in obstructive pulmonary diseaseV Carrieri-Kohlman, J M Gormley, S Eiser, et al.
Archives of General Psychiatry|October 1, 1989
Increased numbers of CD5+ B lymphocytes in schizophrenic patientsC G McAllister, M H Rapaport, D Pickar, et al.
Brain Research. Molecular Brain Research|October 1, 1992
Expression of tyrosine hydroxylase in cerebellar Purkinje neurons of the mutant tottering and leaner mouseM C Austin, M Schultzberg, L C Abbott, et al.
Clinical Genetics|May 23, 2013
Mesoaxial polydactyly is a major feature in Bardet-Biedl syndrome patients with LZTFL1 (BBS17) mutationsE Schaefer, J Lauer, M Durand, et al.
Brain Research|May 15, 1989
Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancyR C Drugan, A L Morrow, R Weizman, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|July 8, 2000
Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositisM J Dodd, S L Dibble, C Miaskowski, et al.
Biochemical Pharmacology|January 15, 1988
Purification and characterization of an endogenous protein modulator of radioligand binding to "peripheral-type" benzodiazepine receptors and dihydropyridine Ca2+-channel antagonist binding sitesC R Mantione, M E Goldman, B Martin, et al.
Alzheimer Disease and Associated Disorders|January 1, 1997
The selective muscarinic agonist xanomeline improves both the cognitive deficits and behavioral symptoms of Alzheimer diseaseN C Bodick, W W Offen, H E Shannon, et al.
Pageof 45